DMT

DMT is an indole alkaloid, a simple tryptamine with the formula C12H16N2, structurally related to the neurotransmitter serotonin and to other psychedelics such as psilocin. It occurs widely in the plant kingdom, in species including Psychotria viridis and Mimosa tenuiflora, and research indicates that it is also synthesized within mammalian tissues, though whether it reaches meaningful concentrations in the living human brain remains a matter of debate ^[1][2].

Amazonian peoples have used DMT-containing plants for generations in the brew ayahuasca, in which a DMT source is combined with Banisteriopsis caapi; the latter supplies monoamine oxidase inhibitors that block the rapid breakdown of DMT in the gut and thereby make it orally active ^[2]. The isolated compound was first synthesized in the 19th century, and its psychoactive properties were characterized in the 1950s by the chemist Stephen Szara.

The route of administration strongly shapes the experience. Smoked or injected, DMT takes effect within seconds and fades within minutes, while oral ayahuasca produces a slower onset with effects lasting several hours ^[2]. Reported experiences include vivid visual imagery, distorted perception of time and of the self, ego dissolution, and encounters with seemingly autonomous entities ^[4]. Unusually for a psychedelic, closely spaced repeated doses of DMT do not readily produce tolerance.

Scientifically, DMT's effects are attributed mainly to activation of the 5-HT2A serotonin receptor, which raises cortical excitability and reshapes large-scale brain activity and rhythms in ways tied to its perceptual and ego-dissolving effects ^[1][3][4]. It is among the psychedelics now being examined for psychiatric use; early controlled trials have reported high rates of remission in major and treatment-resistant depression after a single dose, though the studies so far have been small ^[2]. Endogenous DMT has additionally featured in hypotheses connecting it to psychosis and to near-death experiences, ideas that remain unproven and contested ^[2][5].

DMT is a Schedule I controlled substance in the United States and is broadly prohibited under international law, with exemptions in some jurisdictions for religious use of ayahuasca. It is encountered as a smokable freebase and as water-soluble salts, both as an isolated compound and within plant-based preparations.

The biggest risks with DMT are psychological rather than physical. The come-up is famously abrupt and can feel like being fired from a cannon; plenty of people meet fear, panic, or a total loss of control, and a rough experience can be genuinely destabilizing, especially for anyone predisposed to psychosis or in a bad setting. Physically it pushes up heart rate and blood pressure for a short while, so pre-existing heart problems matter. As with other psychedelics there is a small risk of lingering visual disturbances (HPPD).

The serious pharmacological danger lives in the ayahuasca context: because the brew relies on an MAOI to work, mixing it with SSRIs, other antidepressants, stimulants, or serotonergic drugs can tip you into serotonin syndrome, which can be life-threatening; that MAOI also brings food and drug interactions of its own. On the upside, DMT is not considered addictive, it has low abuse potential, and uniquely among psychedelics it does not build tolerance to repeated, closely spaced doses. Deaths from DMT alone are rare and usually involve interactions or underlying conditions. Legally it is Schedule I in the US and Schedule I under the UN Convention on Psychotropic Substances, with narrow religious exemptions for ayahuasca in some places.